Mycoplasma Testing Market by Product & Services, Technique, Application, and End User - Global Forecast to 2022

  • ID: 4319206
  • Report
  • Region: Global
  • 158 Pages
  • Markets and Markets
1 of 5
The Global Mycoplasma Testing Market is Expected to Reach USD 943.4 Million by 2022, at a CAGR of 12.5% from 2017 to 2022

FEATURED COMPANIES

  • B & M Labs
  • Genbio (Canada)
  • Hylabs (Israel)
  • Merck KGaA (Germany)
  • S.A. (Spain)
  • SGS S.A. (Switzerland)
  • MORE

Mycoplasma Testing Market by Product & Services (Kits & Reagent and Instruments), Technique (PCR, ELSA, Enzymatic Methods, and DNA Staining), Application (Cell Line Testing and Virus Testing), End User (Pharmaceutical Companies and Cell Banks) - Global Forecast to 2022

The global mycoplasma testing market is expected to reach USD 943.4 million by 2022, at a CAGR of 12.5% from 2017 to 2022. The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination. On the other hand, the growth of this market is hindered to some extent due to the stringent regulatory framework & time-consuming approval processes and the high degree of consolidation which acts as an entry barrier for new companies.

"Mycoplasma testing market to register the highest CAGR during the forecast period"

On the basis of products, the mycoplasma testing market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to grow at a higher rate during the forecast period. This is attributed to the frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques.

"Pharmaceutical and biotechnology companies to dominate the mycoplasma testing market during the forecast period"

Based on end users, the mycoplasma testing market is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), cell banks, and other end users. In 2017, pharmaceutical and biotechnology companies segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to the other segments. This can be attributed to the increasing R&D investments in the pharmaceutical industry.

"Asia is estimated to be the fastest growing regional segment in the global mycoplasma testing market during the forecast period"

Geographically, the mycoplasma testing market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 37%, Tier 2 - 47%, Tier 3 - 16%
  • By Designation: C level - 46%, Director level - 36%, Others - 18%
  • By Region: North America - 26%, Europe - 30%, APAC - 22%, South America - 13% and Middle East & Africa: 9%

The key players in the market are Thermo Fisher Scientific Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), SGS S.A. (Switzerland), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.), InvivoGen (U.S.), PromoCell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd., WuXi AppTec (U.S.), Norgen Biotek Corp. (Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A (Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories (U.S.), GeneCopoeia, Inc. (U.S.), GenBio (Canada), Hylabs (Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc. (U.S.), Sartorius AG (Germany), Savyon Diagnostics (Israel), and ScienCell Research Laboratories, Inc. (Canada).

Study Coverage

The report analyses the mycoplasma testing market by product, technique, application, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

Key benefits of buying the Report

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the mycoplasma testing market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the mycoplasma testing market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the mycoplasma testing market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various mycoplasma testing products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the mycoplasma testing market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • B & M Labs
  • Genbio (Canada)
  • Hylabs (Israel)
  • Merck KGaA (Germany)
  • S.A. (Spain)
  • SGS S.A. (Switzerland)
  • MORE

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Market Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown & Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary

4 Mycoplasma Testing Market: Premium Insights
    4.1 Mycoplasma Testing: Market Overview
    4.2 Geographic Analysis: By Application (2017)
    4.3 By Product and Service, 2017-2022
    4.4 Geographical Snapshot of the global market

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Growth and Government Support for Pharmaceutical and Biotechnology Industries
                    5.2.1.2 Strong Trend of R&D Investments in Life Sciences
                    5.2.1.3 Cell Culture Contamination—A Major Concern for Laboratories
           5.2.2 Restraints
                    5.2.2.1 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
                    5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Pharmaceutical and Biotechnology Companies
           5.2.3 Opportunity
                    5.2.3.1 Increasing Pharmaceutical Outsourcing
           5.2.4 Challenge
                    5.2.4.1 Shortage of Skilled Professionals

6 Mycoplasma Testing Market, By Product & Service
    6.1 Introduction
    6.2 Kits & Reagents
           6.2.1 PCR Assays
           6.2.2 Nucleic Acid Detection Kits
           6.2.3 Elimination Kits & Reagents
           6.2.4 Stains
           6.2.5 Standards & Controls
           6.2.6 Other Kits & Reagents
    6.3 Instruments
    6.4 Services

7 Mycoplasma Testing Market, By Technique
    7.1 Introduction
    7.2 PCR
    7.3 Elisa
    7.4 Direct Assays
    7.5 Indirect Assays
    7.6 Dna Staining
    7.7 Microbial Culture Techniques
    7.8 Enzymatic Methods

8 Mycoplasma Testing Market, By Application
    8.1 Introduction
    8.2 Cell Line Testing
    8.3 Virus Testing
    8.4 End-Of-Production Cell Testing
    8.5 Other Applications

9 Mycoplasma Testing Market, By End User
    9.1 Introduction
    9.2 Pharmaceutical and Biotechnology Companies
    9.3 Contract Research Organizations
    9.4 Academic Research Institutes
    9.5 Cell Banks
    9.6 Other End Users

10 Geographic Analysis
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (RoE)
     10.4 Asia
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia (RoA)
     10.5 Rest of the World (RoW)

11 Competitive Landscape
     11.1 Introduction
     11.2 Vendor Dive Overview
             11.2.1 Vanguards
             11.2.2 Innovators
             11.2.3 Dynamic
             11.2.4 Emerging
     11.3 Competitive Benchmarking
             11.3.1 Analysis of Product Portfolio of Major Players in Mycoplasma Teting Market (25 Players)
             11.3.2 Business Strategies Adopted By Major Players in the Mycoplasma Testing Market(25 Players)

Top 25 Companies Analyzed for This Studies are: Charles River Laboratories International, Inc.(U.S.), Merck KGaA (Germany), Roche Diagnostics (Switzerland), Lonza Group Ltd. (Switzerland), SGS S.A. (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.), Invivogen (U.S.), Promo Cell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd, Wuxi Apptec.(U.S.), Norgen Biotek Corp.(Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A.(Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories(U.S.), Genecopoeia Inc.(U.S.), Genbio(Canada), Hylabs(Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc.(U.S.), Sartorius AG (Germany), Savyon Diagnostics(Israel), Sciencell Research Laboratories, Inc.(Canada)

12 Company Profiles
     12.1 Charles River Laboratories International, Inc.
     12.2 Merck KGaA
     12.3 Lonza Group Ltd.
     12.4 Roche Diagnostics (Division of F. Hoffman-LA Roche Ltd.)
     12.5 SGS S.A.
     12.6 Thermo Fisher Scientific Inc.
     12.7 American Type Culture Collection
     12.8 Biounique Testing Laboratories Inc.
     12.9 Invivogen
     12.10 Promocell GmbH
     12.11 Biological Industries Israel Beit Haemek Ltd.
     12.12 Wuxi Apptec
     12.13 Norgen Biotek Corporation

List of Tables
Table 1 Mycoplasma Testing: Market Snapshot
Table 2 Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 3 Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022(USD Million)
Table 4 Mycoplasma Testing Kits & Reagents Market Size, By Region, 2015-2022 (USD Million)
Table 5 PCR Assays Market Size, By Region, 2015-2022 (USD Million)
Table 6 Nucleic Acid Detection Kits Market Size, By Region, 2015-2022 (USD Million)
Table 7 Elimination Kits & Reagents Market Size, By Region, 2015-2022 (USD Million)
Table 8 Mycoplasma Testing Stains Market Size, By Region, 2015-2022 (USD Million)
Table 9 Standards & Controls Market Size, By Region, 2015-2022 (USD Million)
Table 10 Other Kits & Reagents Market Size, By Region, 2015-2022 (USD Million)
Table 11 Mycoplasma Testing Instruments Market Size, By Region, 2015-2022 (USD Million)
Table 12 Mycoplasma Testing Services Market Size, By Region, 2015-2022 (USD Million)
Table 13 Mycoplasma Testing Market Size, By Technique, 2015-2022 (USD Million)
Table 14 Market Size for PCR, By Region, 2015-2022 (USD Million)
Table 15 Elisa Method Market Size, By Region, 2015-2022 (USD Million)
Table 16 Direct Assays Market Size, By Region, 2015-2022 (USD Million)
Table 17 Indirect Assays Market Size, By Region, 2015-2022 (USD Million)
Table 18 Dna Staining Market Size, By Region, 2015-2022 (USD Million)
Table 19 Microbial Culture Techniques Market Size, By Region, 2015- 2022 (USD Million)
Table 20 Enzymatic Methods Market Size, By Region, 2015-2022 (USD Million)
Table 21 Mycoplasma Testing Market Size, By Application, 2015-2022 (USD Million)
Table 22 Market Size for Cell Line Testing, By Region, 2015-2022 (USD Million)
Table 23 Market Size for Virus Testing, By Region, 2015-2022 (USD Million)
Table 24 Market Size for End-Of-Production Cell Testing, By Region, 2015-2022 (USD Million)
Table 25 Other Mycoplasma Testing Applications Market Size, By Region, 2015-2022 (USD Million)
Table 26 Mycoplasma Testing Market Size, By End User, 2015-2022 (USD Million)
Table 27 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 28 Market Size for Contract Research Organizations, By Region, 2015-2022 (USD Million)
Table 29 Market Size for Academic Research Institutes, By Region, 2015-2022 (USD Million)
Table 30 Market Size for Cell Banks, By Region, 2015-2022 (USD Million)
Table 31 Mycoplasma Testing Market Size for Other End Users, By Region, 2015-2022 (USD Million)
Table 32 Market Size, By Region, 2015-2022 (USD Million)
Table 33 North America: Mycoplasma Testing Market Size, By Country, 2015-2022 (USD Million)
Table 34 North America: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 35 North America: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 36 North America: Mycoplasma Testing Market Size, By Technique, 2015-2022 (USD Million)
Table 37 North America: Market Size, By Application, 2015-2022 (USD Million)
Table 38 North America: Market Size, By End User, 2015-2022 (USD Million)
Table 39 U.S.: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 40 U.S.: Market Size, By Technique, 2015-2022 (USD Million)
Table 41 U.S.: Market Size, By Application, 2015-2022 (USD Million)
Table 42 U.S.: Market Size, By End User, 2015-2022 (USD Million)
Table 43 Canada: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 44 Canada: Market Size, By Technique, 2015-2022 (USD Million)
Table 45 Canada: Market Size, By Application, 2015-2022 (USD Million)
Table 46 Canada: Market Size, By End User, 2015-2022 (USD Million)
Table 47 Europe: Mycoplasma Testing Market Size, By Country, 2015-2022 (USD Million)
Table 48 Europe: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 49 Europe: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 50 Europe: Market Size, By Technique, 2015-2022 (USD Million)
Table 51 Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 52 Europe: Market Size, By End User, 2015-2022 (USD Million)
Table 53 Germany: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 54 U.K.: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 55 France: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 56 Italy: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 57 Spain: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 58 RoE: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 59 Asia: Mycoplasma Testing Market Size, By Country, 2015-2022 (USD Million)
Table 60 Asia: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 61 Asia: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 62 Asia: Market Size, By Technique, 2015-2022 (USD Million)
Table 63 Asia: Market Size, By Application, 2015-2022 (USD Million)
Table 64 Asia: Market Size, By End User, 2015-2022 (USD Million)
Table 65 China: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 66 Japan: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 67 India: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 68 RoA: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 69 RoW: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 70 RoW: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 71 RoW: Market Size, By Technique, 2015-2022 (USD Million)
Table 72 RoW: Market Size, By Application, 2015-2022 (USD Million)
Table 73 RoW: Mycoplasma Testing Market Size, By End User, 2015-2022 (USD Million)

List of Figures
Figure 1 Global Mycoplasma Testing Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product and Service, 2017 vs 2022 (USD Million)
Figure 8 Mycoplasma Testing Kits and Reagents Market Size, By Type, 2017 vs 2022 (USD Million)
Figure 9 Mycoplasma Testing Market Size, By Technique, 2017 vs 2022 (USD Million)
Figure 10 Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 11 Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 12 Market Size, By Region, 2017 vs 2022 (USD Million)
Figure 13 Growing Pharmaceutical and Biotechnological Industries - Major Factor Driving Market Growth
Figure 14 Cell Line Testing Segment to Command the Largest Market Share in 2017
Figure 15 Services Segment to Register the Highest CAGR During the Forecast Period
Figure 16 Asia to Register the Highest CAGR Between 2017 & 2022
Figure 17 Mycoplasma Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Kits & Reagents is Expected to Command the Largest Share of the Market in 2017
Figure 19 Global Market, By Technique
Figure 20 Cell Line Testing Will Be the Fastest-Growing Application Segment Durng Forecast Period
Figure 21 Pharmaceutical & Biotechnology Companies Segment to Dominate the Market in 2017
Figure 22 Asia to Register the Highest CAGR During the Forecast Period
Figure 23 U.S. to Dominate the North American Market in 2022
Figure 24 North America: Mycoplasma Testing Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Germany to Register the Highest CAGR in the European Market During the Forecast Period
Figure 27 China Will Continue to Dominate the Asian Market in 2022
Figure 28 Asia: Mycoplasma Testing Market Snapshot
Figure 29 RoW: Mycoplasma Testing Market Snapshot
Figure 30 Dive Chart
Figure 31 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 32 Merck KGaA: Company Snapshot (2016)
Figure 33 Lonza Group Ltd.: Company Snapshot (2016)
Figure 34 F. Hoffmann-LA Roche Ltd.: Company Snapshot (2016)
Figure 35 SGS S.A.: Company Snapshot (2016)
Figure 36 Thermo Fisher Scientific Inc.: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • B & M Labs
  • Genbio (Canada)
  • Hylabs (Israel)
  • Merck KGaA (Germany)
  • S.A. (Spain)
  • SGS S.A. (Switzerland)
  • MORE

The global mycoplasma testing market is expected to reach USD 943.4 Million by 2022 from USD 523.3 Million in 2017, at a CAGR of 12.5%.

The increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination are expected to drive the growth of this market.

The global market is segmented by product, technique, application, end user, and region. By product, the market is segmented into kits & reagent, services, and instruments. The kits & reagent segment is expected to lead the global market in 2017. The frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques are the key factors driving the growth of this segment.

On the basis of technique, the market is classified into PCR, ELISA, direct assays, indirect assays, DNA staining, microbial culture techniques, and enzymatic methods. The PCR segment is expected to account for the largest share of the market in 2017 due it the high acceptance rate of PCR, which can be attributed to its accuracy, speed, and flexibility in life sciences research.

On the basis of application, the mycoplasma testing market is segmented into cell line testing, virus testing, end-of-production cell testing, and other applications. Cell line testing segment accounts for the largest segment and is also the fastest growing application segment in the market. Increasing use of cell lines for research and biopharmaceutical production is the major factor driving the growth of this market.

On the basis of end users, the equipment market is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), cell banks, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share and is projected to register the highest rate during the forecast period. R&D investments in the pharmaceutical industry are one of the major factors fueling the growth of this segment.

The global mycoplasma testing market is dominated by North America, followed by Europe. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centered at China, Japan, and India. The increase in generics development and manufacturing is a major growth driver for the pharmaceutical industry in this region. Growing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing are some factors propelling market growth in the Asian region.

Major industry players expand across geographies via partnerships and acquisitions in the future. Thermo Fisher Scientific Inc., Lonza Group Ltd., Merck KGaA, and Charles River Laboratories International Inc. have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. These companies have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.

Note: Product cover images may vary from those shown
5 of 5
  • Agilent Technologies (U.S.)
  • American Type Culture Collection (U.S.)
  • B & M Labs
  • Biological Industries Israel Beit Haemek Ltd
  • Bionique Testing Laboratories Inc. (U.S.)
  • Biotools
  • Charles River Laboratories International Inc. (U.S.)
  • Eurofins Scientific (Luxembourg)
  • Genbio (Canada)
  • Genecopoeia Inc. (U.S.)
  • Gibraltar Laboratories (U.S.)
  • Hylabs (Israel)
  • Invivogen (U.S.)
  • Lonza Group Ltd. (Switzerland)
  • Merck KGaA (Germany)
  • Meridian Bioscience Inc. (U.S.)
  • Minerva Biolabs GmbH (Germany)
  • Norgen Biotek Corp. (Canada)
  • Promo Cell GmbH (Germany)
  • Roche Diagnostics (Switzerland)
  • S.A. (Spain)
  • Sartorius AG (Germany)
  • Savyon Diagnostics (Israel)
  • Sciencell Research Laboratories Inc. (Canada)
  • SGS S.A. (Switzerland)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Wuxi Apptec. (U.S.)
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll